Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin for Post-ERCP Pancreatitis
NCT02110810Phase 3Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indomethacin in acute pancreatitis (AP), sponsored by Instituto Mexicano del Seguro Social. Started Jan 2014; status: completed.
02
Drugs
indomethacin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02110810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02110810.